{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:59:10Z","timestamp":1791874750657,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T00:00:00Z","timestamp":1504569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T00:00:00Z","timestamp":1504569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The prevailing view is that therapeutic antibodies deplete cells through opsonization and subsequent phagocytosis, complement-dependent lysis or antibody-dependent cellular-cytotoxicity. We used high resolution <jats:italic>in vivo<\/jats:italic> imaging to identify a new antibody-dependent cell death pathway where Kupffer cells ripped large fragments off crawling antibody-coated iNKT cells. This antibody-dependent fragmentation process resulted in lethality and depletion of crawling iNKT cells in the liver sinusoids and lung capillaries. iNKT cell depletion was Fcy-receptor dependent and required iNKT cell crawling. Blood, spleen or joint iNKT cells that did not crawl were not depleted. The antibody required high glycosylation for sufficiently strong binding of the iNKT cells to the Fc Receptors on Kupffer cells. Using an acetaminophen overdose model, this approach functionally depleted hepatic iNKT cells and affected the severity of liver injury. This study reveals a new mechanism of antibody-dependent killing <jats:italic>in vivo<\/jats:italic> and raises implications for the design of new antibodies for cancer and auto-reactive immune cells.<\/jats:p>","DOI":"10.1038\/s41598-017-10420-z","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T11:42:44Z","timestamp":1504093364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Antibody-dependent fragmentation is a newly identified mechanism of cell killing in vivo"],"prefix":"10.1038","volume":"7","author":[{"given":"Pei Xiong","family":"Liew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kubes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,5]]},"reference":[{"key":"10420_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nrc3236","volume":"12","author":"AM Scott","year":"2012","unstructured":"Scott, A. M., Wolchok, J. D. & Old, L. J. Antibody therapy of cancer. Nature reviews. Cancer \n                           12, 278\u2013287, doi:10.1038\/nrc3236 (2012).","journal-title":"Nature reviews. Cancer"},{"key":"10420_CR2","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1182\/blood-2010-07-298356","volume":"117","author":"W Alduaij","year":"2011","unstructured":"Alduaij, W. & Illidge, T. M. The future of anti-CD20 monoclonal antibodies: are we making progress? Blood \n                           117, 2993\u20133001, doi:10.1182\/blood-2010-07-298356 (2011).","journal-title":"Blood"},{"key":"10420_CR3","doi-asserted-by":"publisher","unstructured":"Teillaud, J. L. Antibody-dependent Cellular Cytotoxicity (ADCC) in eLS (Encyclopedia of Life Sciences). John Wiley & Sons Ltd, Chichester, doi:10.1002\/9780470015902.a0000498.pub2 (2012)","DOI":"10.1002\/9780470015902.a0000498.pub2"},{"key":"10420_CR4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc2209","volume":"7","author":"LM Weiner","year":"2007","unstructured":"Weiner, L. M. Building better magic bullets\u2013improving unconjugated monoclonal antibody therapy for cancer. Nature reviews. Cancer \n                           7, 701\u2013706, doi:10.1038\/nrc2209 (2007).","journal-title":"Nature reviews. Cancer"},{"key":"10420_CR5","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.1172\/JCI70972","volume":"123","author":"F Montalvao","year":"2013","unstructured":"Montalvao, F. et al. The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging. The Journal of clinical investigation \n                           123, 5098\u20135103, doi:10.1172\/JCI70972 (2013).","journal-title":"The Journal of clinical investigation"},{"key":"10420_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/srep34382","volume":"6","author":"CL Grandjean","year":"2016","unstructured":"Grandjean, C. L. et al. Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies. Sci Rep \n                           6, 34382, doi:10.1038\/srep34382 (2016).","journal-title":"Sci Rep"},{"key":"10420_CR7","doi-asserted-by":"publisher","unstructured":"Valgardsdottir, R. et al. Human neutrophils mediate trogocytosis rather than phagocytosis of CLL B-cells opsonized with anti-CD20 antibodies. Blood, doi:10.1182\/blood-2016-08-735605 (2017).","DOI":"10.1182\/blood-2016-08-735605"},{"key":"10420_CR8","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1158\/1535-7163.MCT-15-0335","volume":"15","author":"R Velmurugan","year":"2016","unstructured":"Velmurugan, R., Challa, D. K., Ram, S., Ober, R. J. & Ward, E. S. Macrophage-Mediated Trogocytosis Leads to Death of Antibody-Opsonized Tumor Cells. Mol Cancer Ther \n                           15, 1879\u20131889, doi:10.1158\/1535-7163.MCT-15-0335 (2016).","journal-title":"Mol Cancer Ther"},{"key":"10420_CR9","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1182\/blood-2014-10-569244","volume":"125","author":"RP Taylor","year":"2015","unstructured":"Taylor, R. P. & Lindorfer, M. A. Fcgamma-receptor-mediated trogocytosis impacts mAb-based therapies: historical precedence and recent developments. Blood \n                           125, 762\u2013766, doi:10.1182\/blood-2014-10-569244 (2015).","journal-title":"Blood"},{"key":"10420_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nri2747","volume":"10","author":"A Beck","year":"2010","unstructured":"Beck, A., Wurch, T., Bailly, C. & Corvaia, N. Strategies and challenges for the next generation of therapeutic antibodies. Nature reviews. Immunology \n                           10, 345\u2013352, doi:10.1038\/nri2747 (2010).","journal-title":"Nature reviews. Immunology"},{"key":"10420_CR11","doi-asserted-by":"publisher","first-page":"482","DOI":"10.2174\/138920108786786411","volume":"9","author":"A Beck","year":"2008","unstructured":"Beck, A. et al. Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteins. Current pharmaceutical biotechnology \n                           9, 482\u2013501 (2008).","journal-title":"Current pharmaceutical biotechnology"},{"key":"10420_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nri2744","volume":"10","author":"LM Weiner","year":"2010","unstructured":"Weiner, L. M., Surana, R. & Wang, S. Monoclonal antibodies: versatile platforms for cancer immunotherapy. Nature reviews. Immunology \n                           10, 317\u2013327, doi:10.1038\/nri2744 (2010).","journal-title":"Nature reviews. Immunology"},{"key":"10420_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nri2761","volume":"10","author":"AC Chan","year":"2010","unstructured":"Chan, A. C. & Carter, P. J. Therapeutic antibodies for autoimmunity and inflammation. Nature reviews. Immunology \n                           10, 301\u2013316, doi:10.1038\/nri2761 (2010).","journal-title":"Nature reviews. Immunology"},{"key":"10420_CR14","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1056\/NEJMct1114348","volume":"366","author":"DG Maloney","year":"2012","unstructured":"Maloney, D. G. Anti-CD20 antibody therapy for B-cell lymphomas. The New England journal of medicine \n                           366, 2008\u20132016, doi:10.1056\/NEJMct1114348 (2012).","journal-title":"The New England journal of medicine"},{"key":"10420_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/1756285614563522","volume":"8","author":"E Havrdova","year":"2015","unstructured":"Havrdova, E., Horakova, D. & Kovarova, I. Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use. Ther Adv Neurol Diso \n                           8, 31\u201345, doi:10.1177\/1756285614563522 (2015).","journal-title":"Ther Adv Neurol Diso"},{"key":"10420_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0132-3","volume":"12","author":"P Lavaud","year":"2014","unstructured":"Lavaud, P. & Andre, F. Strategies to overcome trastuzumab resistance in HER2-overexpressing breast cancers: focus on new data from clinical trials. BMC medicine \n                           12, 132, doi:10.1186\/s12916-014-0132-3 (2014).","journal-title":"BMC medicine"},{"key":"10420_CR17","first-page":"134","volume":"7","author":"MH Yazdi","year":"2015","unstructured":"Yazdi, M. H., Faramarzi, M. A., Nikfar, S. & Abdollahi, M. A Comprehensive Review of Clinical Trials on EGFR Inhibitors Such as Cetuximab and Panitumumab as Monotherapy and in Combination for Treatment of Metastatic Colorectal Cancer. Avicenna journal of medical biotechnology \n                           7, 134\u2013144 (2015).","journal-title":"Avicenna journal of medical biotechnology"},{"key":"10420_CR18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.4049\/jimmunol.1202448","volume":"190","author":"KD Cook","year":"2013","unstructured":"Cook, K. D. & Whitmire, J. K. The Depletion of NK Cells Prevents T Cell Exhaustion to Efficiently Control Disseminating Virus Infection. Journal of Immunology \n                           190, 641\u2013649, doi:10.4049\/jimmunol.1202448 (2013).","journal-title":"Journal of Immunology"},{"key":"10420_CR19","doi-asserted-by":"publisher","unstructured":"Monnier, J. & Zabel, B. A. Anti-Asialo GM1 NK Cell Depleting Antibody Does Not Alter the Development of Bleomycin Induced Pulmonary Fibrosis. Plos One \n                           9, doi:10.1371\/journal.pone.0099350 (2014).","DOI":"10.1371\/journal.pone.0099350"},{"key":"10420_CR20","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1073\/pnas.0609692104","volume":"104","author":"T Walzer","year":"2007","unstructured":"Walzer, T. et al. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proceedings of the National Academy of Sciences of the United States of America \n                           104, 3384\u20133389, doi:10.1073\/pnas.0609692104 (2007).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10420_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1074-7613(02)00365-5","volume":"17","author":"S Jung","year":"2002","unstructured":"Jung, S. et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity \n                           17, 211\u2013220 (2002).","journal-title":"Immunity"},{"key":"10420_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1189\/jlb.0407247","volume":"83","author":"JM Daley","year":"2008","unstructured":"Daley, J. M., Thomay, A. A., Connolly, M. D., Reichner, J. S. & Albina, J. E. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukocyte Biol \n                           83, 64\u201370, doi:10.1189\/Jlb.0407247 (2008).","journal-title":"J Leukocyte Biol"},{"key":"10420_CR23","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1002\/eji.201041363","volume":"41","author":"KD Carr","year":"2011","unstructured":"Carr, K. D. et al. Specific depletion reveals a novel role for neutrophil-mediated protection in the liver during Listeria monocytogenes infection. European journal of immunology \n                           41, 2666\u20132676, doi:10.1002\/eji.201041363 (2011).","journal-title":"European journal of immunology"},{"key":"10420_CR24","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1128\/IAI.01989-05","volume":"74","author":"S Arora","year":"2006","unstructured":"Arora, S., McDonald, R. A., Toews, G. B. & Huffnagle, G. B. Effect of a CD4-depleting antibody on the development of Cryptococcus neoformans-induced allergic bronchopulmonary mycosis in mice. Infection and immunity \n                           74, 4339\u20134348, doi:10.1128\/IAI.01989-05 (2006).","journal-title":"Infection and immunity"},{"key":"10420_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1165\/ajrcmb.10.6.8003337","volume":"10","author":"SH Gavett","year":"1994","unstructured":"Gavett, S. H., Chen, X., Finkelman, F. & Wills-Karp, M. Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. American journal of respiratory cell and molecular biology \n                           10, 587\u2013593, doi:10.1165\/ajrcmb.10.6.8003337 (1994).","journal-title":"American journal of respiratory cell and molecular biology"},{"key":"10420_CR26","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.4049\/jimmunol.168.7.3493","volume":"168","author":"HP Jones","year":"2002","unstructured":"Jones, H. P., Tabor, L., Sun, X., Woolard, M. D. & Simecka, J. W. Depletion of CD8+ T cells exacerbates CD4+ Th cell-associated inflammatory lesions during murine mycoplasma respiratory disease. J Immunol \n                           168, 3493\u20133501 (2002).","journal-title":"J Immunol"},{"key":"10420_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1128\/IAI.68.1.352-359.2000","volume":"68","author":"LE Cano","year":"2000","unstructured":"Cano, L. E. et al. Depletion of CD8(+) T cells in vivo impairs host defense of mice resistant and susceptible to pulmonary paracoccidioidomycosis. Infection and immunity \n                           68, 352\u2013359 (2000).","journal-title":"Infection and immunity"},{"key":"10420_CR28","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1681\/ASN.2006060622","volume":"18","author":"H Wu","year":"2007","unstructured":"Wu, H. et al. Depletion of gammadelta T cells exacerbates murine adriamycin nephropathy. Journal of the American Society of Nephrology: JASN \n                           18, 1180\u20131189, doi:10.1681\/ASN.2006060622 (2007).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10420_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140729","volume":"10","author":"F Scheuplein","year":"2015","unstructured":"Scheuplein, F. et al. Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo. Plos One \n                           10, e0140729, doi:10.1371\/journal.pone.0140729 (2015).","journal-title":"Plos One"},{"key":"10420_CR30","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/eji.200939613","volume":"40","author":"YY Setiady","year":"2010","unstructured":"Setiady, Y. Y., Coccia, J. A. & Park, P. U. In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes. European journal of immunology \n                           40, 780\u2013786, doi:10.1002\/eji.200939613 (2010).","journal-title":"European journal of immunology"},{"key":"10420_CR31","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1002\/jps.24444","volume":"104","author":"L Liu","year":"2015","unstructured":"Liu, L. Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins. Journal of pharmaceutical sciences \n                           104, 1866\u20131884, doi:10.1002\/jps.24444 (2015).","journal-title":"Journal of pharmaceutical sciences"},{"key":"10420_CR32","doi-asserted-by":"publisher","first-page":"896","DOI":"10.4161\/mabs.26436","volume":"5","author":"MK Leabman","year":"2013","unstructured":"Leabman, M. K. et al. Effects of altered FcgammaR binding on antibody pharmacokinetics in cynomolgus monkeys. mAbs \n                           5, 896\u2013903, doi:10.4161\/mabs.26436 (2013).","journal-title":"mAbs"},{"key":"10420_CR33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrd2909","volume":"11","author":"PM Hogarth","year":"2012","unstructured":"Hogarth, P. M. & Pietersz, G. A. Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond. Nature reviews. Drug discovery \n                           11, 311\u2013331, doi:10.1038\/nrd2909 (2012).","journal-title":"Nature reviews. Drug discovery"},{"key":"10420_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-5-64","volume":"5","author":"S Cang","year":"2012","unstructured":"Cang, S., Mukhi, N., Wang, K. & Liu, D. Novel CD20 monoclonal antibodies for lymphoma therapy. Journal of hematology & oncology \n                           5, 64, doi:10.1186\/1756-8722-5-64 (2012).","journal-title":"Journal of hematology & oncology"},{"key":"10420_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4161\/mabs.20996","volume":"4","author":"A Beck","year":"2012","unstructured":"Beck, A. & Reichert, J. M. Marketing approval of mogamulizumab: a triumph for glyco-engineering. mAbs \n                           4, 419\u2013425, doi:10.4161\/mabs.20996 (2012).","journal-title":"mAbs"},{"key":"10420_CR36","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1172\/JCI77837","volume":"124","author":"CR Mackay","year":"2014","unstructured":"Mackay, C. R. CXCR3(+) CCR5(+) T cells and autoimmune diseases: guilty as charged? The Journal of clinical investigation \n                           124, 3682\u20133684, doi:10.1172\/JCI77837 (2014).","journal-title":"The Journal of clinical investigation"},{"key":"10420_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00012","volume":"6","author":"M Vela","year":"2015","unstructured":"Vela, M., Aris, M., Llorente, M., Garcia-Sanz, J. A. & Kremer, L. Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges. Frontiers in immunology \n                           6, 12, doi:10.3389\/fimmu.2015.00012 (2015).","journal-title":"Frontiers in immunology"},{"key":"10420_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0030113","volume":"3","author":"F Geissmann","year":"2005","unstructured":"Geissmann, F. et al. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS biology \n                           3, e113, doi:10.1371\/journal.pbio.0030113 (2005).","journal-title":"PLoS biology"},{"key":"10420_CR39","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ni.1855","volume":"11","author":"WY Lee","year":"2010","unstructured":"Lee, W. Y. et al. An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nat Immunol \n                           11, 295\u2013U236, doi:10.1038\/Ni.1855 (2010).","journal-title":"Nat Immunol"},{"key":"10420_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1126\/science.1210301","volume":"334","author":"CHY Wong","year":"2011","unstructured":"Wong, C. H. Y., Jenne, C. N., Lee, W. Y., Leger, C. & Kubes, P. Functional Innervation of Hepatic iNKT Cells Is Immunosuppressive Following Stroke. Science \n                           334, 101\u2013105, doi:10.1126\/science.1210301 (2011).","journal-title":"Science"},{"key":"10420_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/icb.2010.158","volume":"89","author":"JR Groom","year":"2011","unstructured":"Groom, J. R. & Luster, A. D. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol \n                           89, 207\u2013215, doi:10.1038\/icb.2010.158 (2011).","journal-title":"Immunol Cell Biol"},{"key":"10420_CR42","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1749-6632.2009.04813.x","volume":"1173","author":"S Lacotte","year":"2009","unstructured":"Lacotte, S., Brun, S., Muller, S. & Dumortier, H. CXCR3, inflammation, and autoimmune diseases. Annals of the New York Academy of Sciences \n                           1173, 310\u2013317, doi:10.1111\/j.1749-6632.2009.04813.x (2009).","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10420_CR43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/TP.0b013e31817b8e4b","volume":"86","author":"R Uppaluri","year":"2008","unstructured":"Uppaluri, R. et al. Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody. Transplantation \n                           86, 137\u2013147, doi:10.1097\/Tp.0b013e31817b8e4b (2008).","journal-title":"Transplantation"},{"key":"10420_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","volume":"184","author":"I Vermes","year":"1995","unstructured":"Vermes, I., Haanen, C., Steffens-Nakken, H. & Reutelingsperger, C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. Journal of immunological methods \n                           184, 39\u201351 (1995).","journal-title":"Journal of immunological methods"},{"key":"10420_CR45","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/S0015-0282(00)01591-0","volume":"74","author":"N Kemal Duru","year":"2000","unstructured":"Kemal Duru, N., Morshedi, M. & Oehninger, S. Effects of hydrogen peroxide on DNA and plasma membrane integrity of human spermatozoa. Fertility and sterility \n                           74, 1200\u20131207 (2000).","journal-title":"Fertility and sterility"},{"key":"10420_CR46","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1128\/AAC.49.6.2445-2453.2005","volume":"49","author":"E Leiter","year":"2005","unstructured":"Leiter, E. et al. Antifungal protein PAF severely affects the integrity of the plasma membrane of Aspergillus nidulans and induces an apoptosis-like phenotype. Antimicrobial agents and chemotherapy \n                           49, 2445\u20132453, doi:10.1128\/AAC.49.6.2445-2453.2005 (2005).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"10420_CR47","doi-asserted-by":"publisher","unstructured":"Wallberg, F., Tenev, T. & Meier, P. Time-Lapse Imaging of Cell Death. Cold Spring Harbor protocols \n                           2016, pdb prot087395, doi:10.1101\/pdb.prot087395 (2016).","DOI":"10.1101\/pdb.prot087395"},{"key":"10420_CR48","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1242\/jcs.093575","volume":"127","author":"SWG Tait","year":"2014","unstructured":"Tait, S. W. G., Ichim, G. & Green, D. R. Die another way - non-apoptotic mechanisms of cell death. J Cell Sci \n                           127, 2135\u20132144, doi:10.1242\/jcs.093575 (2014).","journal-title":"J Cell Sci"},{"key":"10420_CR49","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/icb.2013.6","volume":"91","author":"CHY Wong","year":"2013","unstructured":"Wong, C. H. Y. & Kubes, P. Imaging natural killer T cells in action. Immunol Cell Biol \n                           91, 304\u2013310, doi:10.1038\/Icb.2013.6 (2013).","journal-title":"Immunol Cell Biol"},{"key":"10420_CR50","doi-asserted-by":"publisher","first-page":"13936","DOI":"10.1073\/pnas.1404769111","volume":"111","author":"WY Lee","year":"2014","unstructured":"Lee, W. Y. et al. Invariant natural killer T cells act as an extravascular cytotoxic barrier for joint-invading Lyme Borrelia. Proceedings of the National Academy of Sciences of the United States of America \n                           111, 13936\u201313941, doi:10.1073\/pnas.1404769111 (2014).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10420_CR51","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.4049\/jimmunol.180.4.2024","volume":"180","author":"P Velazquez","year":"2008","unstructured":"Velazquez, P. et al. Cutting edge: activation by innate cytokines or microbial antigens can cause arrest of natural killer T cell patrolling of liver sinusoids. Journal of immunology \n                           180, 2024\u20132028 (2008).","journal-title":"Journal of immunology"},{"key":"10420_CR52","doi-asserted-by":"publisher","DOI":"10.14440\/jbm.2015.52","volume":"2","author":"VS Tayi","year":"2015","unstructured":"Tayi, V. S. & Butler, M. Isolation and quantification of N-glycans from immunoglobulin G antibodies for quantitative glycosylation analysis. Journal of Biological Methods \n                           2, e19, doi:10.14440\/jbm.2015.52 (2015).","journal-title":"Journal of Biological Methods"},{"key":"10420_CR53","doi-asserted-by":"publisher","unstructured":"Magnelli, P. E., Bielik, A. M. & Guthrie, E. P. Identification and characterization of protein glycosylation using specific endo- and exoglycosidases. Journal of visualized experiments: JoVE, e3749, doi:10.3791\/3749 (2011).","DOI":"10.3791\/3749"},{"key":"10420_CR54","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nbt.2885","volume":"32","author":"L Meuris","year":"2014","unstructured":"Meuris, L. et al. GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins. Nature biotechnology \n                           32, 485\u2013489, doi:10.1038\/nbt.2885 (2014).","journal-title":"Nature biotechnology"},{"key":"10420_CR55","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.lfs.2011.01.025","volume":"88","author":"H Jaeschke","year":"2011","unstructured":"Jaeschke, H., McGill, M. R., Williams, C. D. & Ramachandran, A. Current issues with acetaminophen hepatotoxicity\u2013a clinically relevant model to test the efficacy of natural products. Life sciences \n                           88, 737\u2013745, doi:10.1016\/j.lfs.2011.01.025 (2011).","journal-title":"Life sciences"},{"key":"10420_CR56","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/hep.26134","volume":"57","author":"BV Martin-Murphy","year":"2013","unstructured":"Martin-Murphy, B. V., Kominsky, D. J., Orlicky, D. J., Donohue, T. M. Jr. & Ju, C. Increased susceptibility of natural killer T-cell-deficient mice to acetaminophen-induced liver injury. Hepatology \n                           57, 1575\u20131584, doi:10.1002\/hep.26134 (2013).","journal-title":"Hepatology"},{"key":"10420_CR57","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.4049\/jimmunol.1101189","volume":"187","author":"PV Beum","year":"2011","unstructured":"Beum, P. V. et al. Loss of CD20 and bound CD20 antibody from opsonized B cells occurs more rapidly because of trogocytosis mediated by Fc receptor-expressing effector cells than direct internalization by the B cells. J Immunol \n                           187, 3438\u20133447, doi:10.4049\/jimmunol.1101189 (2011).","journal-title":"J Immunol"},{"key":"10420_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00240","volume":"6","author":"PX Liew","year":"2015","unstructured":"Liew, P. X. & Kubes, P. Intravital imaging - dynamic insights into natural killer T cell biology. Frontiers in immunology \n                           6, 240, doi:10.3389\/fimmu.2015.00240 (2015).","journal-title":"Frontiers in immunology"},{"key":"10420_CR59","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.it.2012.08.009","volume":"34","author":"L Van Kaer","year":"2013","unstructured":"Van Kaer, L., Parekh, V. V. & Wu, L. Invariant natural killer T cells as sensors and managers of inflammation. Trends Immunol \n                           34, 50\u201358, doi:10.1016\/J.It.2012.08.009 (2013).","journal-title":"Trends Immunol"},{"key":"10420_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00316","volume":"6","author":"I Marrero","year":"2015","unstructured":"Marrero, I., Ware, R. & Kumar, V. Type II NKT Cells in Inflammation, Autoimmunity, Microbial Immunity, and Cancer. Frontiers in immunology \n                           6, 316, doi:10.3389\/fimmu.2015.00316 (2015).","journal-title":"Frontiers in immunology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10420-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10420-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10420-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T10:19:37Z","timestamp":1671790777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10420-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,5]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["10420"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-10420-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,5]]},"assertion":[{"value":"26 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10515"}}